Global Gastroparesis Drugs Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Gastroparesis Drugs market size was valued at US$ 5535.9 million in 2023. With growing demand in downstream market, the Gastroparesis Drugs is forecast to a readjusted size of US$ 7513.8 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Gastroparesis Drugs market. Gastroparesis Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Gastroparesis Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Gastroparesis Drugs market.
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.
Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.
Key Features:
The report on Gastroparesis Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Gastroparesis Drugs market. It may include historical data, market segmentation by Type (e.g., Prokinetic Agents, Antiemetic Agents), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Gastroparesis Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Gastroparesis Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Gastroparesis Drugs industry. This include advancements in Gastroparesis Drugs technology, Gastroparesis Drugs new entrants, Gastroparesis Drugs new investment, and other innovations that are shaping the future of Gastroparesis Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Gastroparesis Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Gastroparesis Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Gastroparesis Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Gastroparesis Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Gastroparesis Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Gastroparesis Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Gastroparesis Drugs market.
Market Segmentation:
Gastroparesis Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Gastroparesis Drugs market?
What factors are driving Gastroparesis Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gastroparesis Drugs market opportunities vary by end market size?
How does Gastroparesis Drugs break out type, application?
According to our LPI (LP Information) latest study, the global Gastroparesis Drugs market size was valued at US$ 5535.9 million in 2023. With growing demand in downstream market, the Gastroparesis Drugs is forecast to a readjusted size of US$ 7513.8 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Gastroparesis Drugs market. Gastroparesis Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Gastroparesis Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Gastroparesis Drugs market.
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.
Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.
Key Features:
The report on Gastroparesis Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Gastroparesis Drugs market. It may include historical data, market segmentation by Type (e.g., Prokinetic Agents, Antiemetic Agents), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Gastroparesis Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Gastroparesis Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Gastroparesis Drugs industry. This include advancements in Gastroparesis Drugs technology, Gastroparesis Drugs new entrants, Gastroparesis Drugs new investment, and other innovations that are shaping the future of Gastroparesis Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Gastroparesis Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Gastroparesis Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Gastroparesis Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Gastroparesis Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Gastroparesis Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Gastroparesis Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Gastroparesis Drugs market.
Market Segmentation:
Gastroparesis Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Prokinetic Agents
- Antiemetic Agents
- Others
- Diabetic Gastroparesis
- Idiopathic Gastroparesis
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sumitomo
- Cadila Pharmaceuticals
- Sanofi
- Teva
- Johnson & Johnson
- Pfizer
- Kyowa Kirin Pharmaceuticals
- Hanmi Pharm
- Ani Pharmaceuticals
What is the 10-year outlook for the global Gastroparesis Drugs market?
What factors are driving Gastroparesis Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gastroparesis Drugs market opportunities vary by end market size?
How does Gastroparesis Drugs break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastroparesis Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Gastroparesis Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Gastroparesis Drugs by Country/Region, 2019, 2023 & 2030
2.2 Gastroparesis Drugs Segment by Type
2.2.1 Prokinetic Agents
2.2.2 Antiemetic Agents
2.2.3 Others
2.3 Gastroparesis Drugs Sales by Type
2.3.1 Global Gastroparesis Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global Gastroparesis Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Gastroparesis Drugs Sale Price by Type (2019-2024)
2.4 Gastroparesis Drugs Segment by Application
2.4.1 Diabetic Gastroparesis
2.4.2 Idiopathic Gastroparesis
2.5 Gastroparesis Drugs Sales by Application
2.5.1 Global Gastroparesis Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global Gastroparesis Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Gastroparesis Drugs Sale Price by Application (2019-2024)
3 GLOBAL GASTROPARESIS DRUGS BY COMPANY
3.1 Global Gastroparesis Drugs Breakdown Data by Company
3.1.1 Global Gastroparesis Drugs Annual Sales by Company (2019-2024)
3.1.2 Global Gastroparesis Drugs Sales Market Share by Company (2019-2024)
3.2 Global Gastroparesis Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global Gastroparesis Drugs Revenue by Company (2019-2024)
3.2.2 Global Gastroparesis Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Gastroparesis Drugs Sale Price by Company
3.4 Key Manufacturers Gastroparesis Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gastroparesis Drugs Product Location Distribution
3.4.2 Players Gastroparesis Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GASTROPARESIS DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Gastroparesis Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global Gastroparesis Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Gastroparesis Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Gastroparesis Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global Gastroparesis Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Gastroparesis Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Gastroparesis Drugs Sales Growth
4.4 APAC Gastroparesis Drugs Sales Growth
4.5 Europe Gastroparesis Drugs Sales Growth
4.6 Middle East & Africa Gastroparesis Drugs Sales Growth
5 AMERICAS
5.1 Americas Gastroparesis Drugs Sales by Country
5.1.1 Americas Gastroparesis Drugs Sales by Country (2019-2024)
5.1.2 Americas Gastroparesis Drugs Revenue by Country (2019-2024)
5.2 Americas Gastroparesis Drugs Sales by Type
5.3 Americas Gastroparesis Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastroparesis Drugs Sales by Region
6.1.1 APAC Gastroparesis Drugs Sales by Region (2019-2024)
6.1.2 APAC Gastroparesis Drugs Revenue by Region (2019-2024)
6.2 APAC Gastroparesis Drugs Sales by Type
6.3 APAC Gastroparesis Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gastroparesis Drugs by Country
7.1.1 Europe Gastroparesis Drugs Sales by Country (2019-2024)
7.1.2 Europe Gastroparesis Drugs Revenue by Country (2019-2024)
7.2 Europe Gastroparesis Drugs Sales by Type
7.3 Europe Gastroparesis Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastroparesis Drugs by Country
8.1.1 Middle East & Africa Gastroparesis Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Gastroparesis Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Gastroparesis Drugs Sales by Type
8.3 Middle East & Africa Gastroparesis Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gastroparesis Drugs
10.3 Manufacturing Process Analysis of Gastroparesis Drugs
10.4 Industry Chain Structure of Gastroparesis Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gastroparesis Drugs Distributors
11.3 Gastroparesis Drugs Customer
12 WORLD FORECAST REVIEW FOR GASTROPARESIS DRUGS BY GEOGRAPHIC REGION
12.1 Global Gastroparesis Drugs Market Size Forecast by Region
12.1.1 Global Gastroparesis Drugs Forecast by Region (2025-2030)
12.1.2 Global Gastroparesis Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gastroparesis Drugs Forecast by Type
12.7 Global Gastroparesis Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sumitomo
13.1.1 Sumitomo Company Information
13.1.2 Sumitomo Gastroparesis Drugs Product Portfolios and Specifications
13.1.3 Sumitomo Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sumitomo Main Business Overview
13.1.5 Sumitomo Latest Developments
13.2 Cadila Pharmaceuticals
13.2.1 Cadila Pharmaceuticals Company Information
13.2.2 Cadila Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
13.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Cadila Pharmaceuticals Main Business Overview
13.2.5 Cadila Pharmaceuticals Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Gastroparesis Drugs Product Portfolios and Specifications
13.3.3 Sanofi Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Teva
13.4.1 Teva Company Information
13.4.2 Teva Gastroparesis Drugs Product Portfolios and Specifications
13.4.3 Teva Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Teva Main Business Overview
13.4.5 Teva Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Gastroparesis Drugs Product Portfolios and Specifications
13.5.3 Johnson & Johnson Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Gastroparesis Drugs Product Portfolios and Specifications
13.6.3 Pfizer Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Kyowa Kirin Pharmaceuticals
13.7.1 Kyowa Kirin Pharmaceuticals Company Information
13.7.2 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
13.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Kyowa Kirin Pharmaceuticals Main Business Overview
13.7.5 Kyowa Kirin Pharmaceuticals Latest Developments
13.8 Hanmi Pharm
13.8.1 Hanmi Pharm Company Information
13.8.2 Hanmi Pharm Gastroparesis Drugs Product Portfolios and Specifications
13.8.3 Hanmi Pharm Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Hanmi Pharm Main Business Overview
13.8.5 Hanmi Pharm Latest Developments
13.9 Ani Pharmaceuticals
13.9.1 Ani Pharmaceuticals Company Information
13.9.2 Ani Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
13.9.3 Ani Pharmaceuticals Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Ani Pharmaceuticals Main Business Overview
13.9.5 Ani Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastroparesis Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Gastroparesis Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Gastroparesis Drugs by Country/Region, 2019, 2023 & 2030
2.2 Gastroparesis Drugs Segment by Type
2.2.1 Prokinetic Agents
2.2.2 Antiemetic Agents
2.2.3 Others
2.3 Gastroparesis Drugs Sales by Type
2.3.1 Global Gastroparesis Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global Gastroparesis Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Gastroparesis Drugs Sale Price by Type (2019-2024)
2.4 Gastroparesis Drugs Segment by Application
2.4.1 Diabetic Gastroparesis
2.4.2 Idiopathic Gastroparesis
2.5 Gastroparesis Drugs Sales by Application
2.5.1 Global Gastroparesis Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global Gastroparesis Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Gastroparesis Drugs Sale Price by Application (2019-2024)
3 GLOBAL GASTROPARESIS DRUGS BY COMPANY
3.1 Global Gastroparesis Drugs Breakdown Data by Company
3.1.1 Global Gastroparesis Drugs Annual Sales by Company (2019-2024)
3.1.2 Global Gastroparesis Drugs Sales Market Share by Company (2019-2024)
3.2 Global Gastroparesis Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global Gastroparesis Drugs Revenue by Company (2019-2024)
3.2.2 Global Gastroparesis Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Gastroparesis Drugs Sale Price by Company
3.4 Key Manufacturers Gastroparesis Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gastroparesis Drugs Product Location Distribution
3.4.2 Players Gastroparesis Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GASTROPARESIS DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Gastroparesis Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global Gastroparesis Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Gastroparesis Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Gastroparesis Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global Gastroparesis Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Gastroparesis Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Gastroparesis Drugs Sales Growth
4.4 APAC Gastroparesis Drugs Sales Growth
4.5 Europe Gastroparesis Drugs Sales Growth
4.6 Middle East & Africa Gastroparesis Drugs Sales Growth
5 AMERICAS
5.1 Americas Gastroparesis Drugs Sales by Country
5.1.1 Americas Gastroparesis Drugs Sales by Country (2019-2024)
5.1.2 Americas Gastroparesis Drugs Revenue by Country (2019-2024)
5.2 Americas Gastroparesis Drugs Sales by Type
5.3 Americas Gastroparesis Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastroparesis Drugs Sales by Region
6.1.1 APAC Gastroparesis Drugs Sales by Region (2019-2024)
6.1.2 APAC Gastroparesis Drugs Revenue by Region (2019-2024)
6.2 APAC Gastroparesis Drugs Sales by Type
6.3 APAC Gastroparesis Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gastroparesis Drugs by Country
7.1.1 Europe Gastroparesis Drugs Sales by Country (2019-2024)
7.1.2 Europe Gastroparesis Drugs Revenue by Country (2019-2024)
7.2 Europe Gastroparesis Drugs Sales by Type
7.3 Europe Gastroparesis Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastroparesis Drugs by Country
8.1.1 Middle East & Africa Gastroparesis Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Gastroparesis Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Gastroparesis Drugs Sales by Type
8.3 Middle East & Africa Gastroparesis Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gastroparesis Drugs
10.3 Manufacturing Process Analysis of Gastroparesis Drugs
10.4 Industry Chain Structure of Gastroparesis Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gastroparesis Drugs Distributors
11.3 Gastroparesis Drugs Customer
12 WORLD FORECAST REVIEW FOR GASTROPARESIS DRUGS BY GEOGRAPHIC REGION
12.1 Global Gastroparesis Drugs Market Size Forecast by Region
12.1.1 Global Gastroparesis Drugs Forecast by Region (2025-2030)
12.1.2 Global Gastroparesis Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gastroparesis Drugs Forecast by Type
12.7 Global Gastroparesis Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sumitomo
13.1.1 Sumitomo Company Information
13.1.2 Sumitomo Gastroparesis Drugs Product Portfolios and Specifications
13.1.3 Sumitomo Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sumitomo Main Business Overview
13.1.5 Sumitomo Latest Developments
13.2 Cadila Pharmaceuticals
13.2.1 Cadila Pharmaceuticals Company Information
13.2.2 Cadila Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
13.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Cadila Pharmaceuticals Main Business Overview
13.2.5 Cadila Pharmaceuticals Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Gastroparesis Drugs Product Portfolios and Specifications
13.3.3 Sanofi Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Teva
13.4.1 Teva Company Information
13.4.2 Teva Gastroparesis Drugs Product Portfolios and Specifications
13.4.3 Teva Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Teva Main Business Overview
13.4.5 Teva Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Gastroparesis Drugs Product Portfolios and Specifications
13.5.3 Johnson & Johnson Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Gastroparesis Drugs Product Portfolios and Specifications
13.6.3 Pfizer Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Kyowa Kirin Pharmaceuticals
13.7.1 Kyowa Kirin Pharmaceuticals Company Information
13.7.2 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
13.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Kyowa Kirin Pharmaceuticals Main Business Overview
13.7.5 Kyowa Kirin Pharmaceuticals Latest Developments
13.8 Hanmi Pharm
13.8.1 Hanmi Pharm Company Information
13.8.2 Hanmi Pharm Gastroparesis Drugs Product Portfolios and Specifications
13.8.3 Hanmi Pharm Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Hanmi Pharm Main Business Overview
13.8.5 Hanmi Pharm Latest Developments
13.9 Ani Pharmaceuticals
13.9.1 Ani Pharmaceuticals Company Information
13.9.2 Ani Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
13.9.3 Ani Pharmaceuticals Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Ani Pharmaceuticals Main Business Overview
13.9.5 Ani Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gastroparesis Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Gastroparesis Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Prokinetic Agents
Table 4. Major Players of Antiemetic Agents
Table 5. Major Players of Others
Table 6. Global Gastroparesis Drugs Sales by Type (2019-2024) & (Kg)
Table 7. Global Gastroparesis Drugs Sales Market Share by Type (2019-2024)
Table 8. Global Gastroparesis Drugs Revenue by Type (2019-2024) & ($ million)
Table 9. Global Gastroparesis Drugs Revenue Market Share by Type (2019-2024)
Table 10. Global Gastroparesis Drugs Sale Price by Type (2019-2024) & (US$/mg)
Table 11. Global Gastroparesis Drugs Sales by Application (2019-2024) & (Kg)
Table 12. Global Gastroparesis Drugs Sales Market Share by Application (2019-2024)
Table 13. Global Gastroparesis Drugs Revenue by Application (2019-2024)
Table 14. Global Gastroparesis Drugs Revenue Market Share by Application (2019-2024)
Table 15. Global Gastroparesis Drugs Sale Price by Application (2019-2024) & (US$/mg)
Table 16. Global Gastroparesis Drugs Sales by Company (2019-2024) & (Kg)
Table 17. Global Gastroparesis Drugs Sales Market Share by Company (2019-2024)
Table 18. Global Gastroparesis Drugs Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Gastroparesis Drugs Revenue Market Share by Company (2019-2024)
Table 20. Global Gastroparesis Drugs Sale Price by Company (2019-2024) & (US$/mg)
Table 21. Key Manufacturers Gastroparesis Drugs Producing Area Distribution and Sales Area
Table 22. Players Gastroparesis Drugs Products Offered
Table 23. Gastroparesis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Gastroparesis Drugs Sales by Geographic Region (2019-2024) & (Kg)
Table 27. Global Gastroparesis Drugs Sales Market Share Geographic Region (2019-2024)
Table 28. Global Gastroparesis Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Gastroparesis Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Gastroparesis Drugs Sales by Country/Region (2019-2024) & (Kg)
Table 31. Global Gastroparesis Drugs Sales Market Share by Country/Region (2019-2024)
Table 32. Global Gastroparesis Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Gastroparesis Drugs Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Gastroparesis Drugs Sales by Country (2019-2024) & (Kg)
Table 35. Americas Gastroparesis Drugs Sales Market Share by Country (2019-2024)
Table 36. Americas Gastroparesis Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Gastroparesis Drugs Revenue Market Share by Country (2019-2024)
Table 38. Americas Gastroparesis Drugs Sales by Type (2019-2024) & (Kg)
Table 39. Americas Gastroparesis Drugs Sales by Application (2019-2024) & (Kg)
Table 40. APAC Gastroparesis Drugs Sales by Region (2019-2024) & (Kg)
Table 41. APAC Gastroparesis Drugs Sales Market Share by Region (2019-2024)
Table 42. APAC Gastroparesis Drugs Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Gastroparesis Drugs Revenue Market Share by Region (2019-2024)
Table 44. APAC Gastroparesis Drugs Sales by Type (2019-2024) & (Kg)
Table 45. APAC Gastroparesis Drugs Sales by Application (2019-2024) & (Kg)
Table 46. Europe Gastroparesis Drugs Sales by Country (2019-2024) & (Kg)
Table 47. Europe Gastroparesis Drugs Sales Market Share by Country (2019-2024)
Table 48. Europe Gastroparesis Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Gastroparesis Drugs Revenue Market Share by Country (2019-2024)
Table 50. Europe Gastroparesis Drugs Sales by Type (2019-2024) & (Kg)
Table 51. Europe Gastroparesis Drugs Sales by Application (2019-2024) & (Kg)
Table 52. Middle East & Africa Gastroparesis Drugs Sales by Country (2019-2024) & (Kg)
Table 53. Middle East & Africa Gastroparesis Drugs Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Gastroparesis Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Gastroparesis Drugs Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Gastroparesis Drugs Sales by Type (2019-2024) & (Kg)
Table 57. Middle East & Africa Gastroparesis Drugs Sales by Application (2019-2024) & (Kg)
Table 58. Key Market Drivers & Growth Opportunities of Gastroparesis Drugs
Table 59. Key Market Challenges & Risks of Gastroparesis Drugs
Table 60. Key Industry Trends of Gastroparesis Drugs
Table 61. Gastroparesis Drugs Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Gastroparesis Drugs Distributors List
Table 64. Gastroparesis Drugs Customer List
Table 65. Global Gastroparesis Drugs Sales Forecast by Region (2025-2030) & (Kg)
Table 66. Global Gastroparesis Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Gastroparesis Drugs Sales Forecast by Country (2025-2030) & (Kg)
Table 68. Americas Gastroparesis Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Gastroparesis Drugs Sales Forecast by Region (2025-2030) & (Kg)
Table 70. APAC Gastroparesis Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Gastroparesis Drugs Sales Forecast by Country (2025-2030) & (Kg)
Table 72. Europe Gastroparesis Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Gastroparesis Drugs Sales Forecast by Country (2025-2030) & (Kg)
Table 74. Middle East & Africa Gastroparesis Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Gastroparesis Drugs Sales Forecast by Type (2025-2030) & (Kg)
Table 76. Global Gastroparesis Drugs Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Gastroparesis Drugs Sales Forecast by Application (2025-2030) & (Kg)
Table 78. Global Gastroparesis Drugs Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Sumitomo Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Sumitomo Gastroparesis Drugs Product Portfolios and Specifications
Table 81. Sumitomo Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 82. Sumitomo Main Business
Table 83. Sumitomo Latest Developments
Table 84. Cadila Pharmaceuticals Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Cadila Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
Table 86. Cadila Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 87. Cadila Pharmaceuticals Main Business
Table 88. Cadila Pharmaceuticals Latest Developments
Table 89. Sanofi Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Sanofi Gastroparesis Drugs Product Portfolios and Specifications
Table 91. Sanofi Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 92. Sanofi Main Business
Table 93. Sanofi Latest Developments
Table 94. Teva Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Teva Gastroparesis Drugs Product Portfolios and Specifications
Table 96. Teva Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 97. Teva Main Business
Table 98. Teva Latest Developments
Table 99. Johnson & Johnson Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Johnson & Johnson Gastroparesis Drugs Product Portfolios and Specifications
Table 101. Johnson & Johnson Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 102. Johnson & Johnson Main Business
Table 103. Johnson & Johnson Latest Developments
Table 104. Pfizer Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer Gastroparesis Drugs Product Portfolios and Specifications
Table 106. Pfizer Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 107. Pfizer Main Business
Table 108. Pfizer Latest Developments
Table 109. Kyowa Kirin Pharmaceuticals Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
Table 111. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 112. Kyowa Kirin Pharmaceuticals Main Business
Table 113. Kyowa Kirin Pharmaceuticals Latest Developments
Table 114. Hanmi Pharm Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Hanmi Pharm Gastroparesis Drugs Product Portfolios and Specifications
Table 116. Hanmi Pharm Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 117. Hanmi Pharm Main Business
Table 118. Hanmi Pharm Latest Developments
Table 119. Ani Pharmaceuticals Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Ani Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
Table 121. Ani Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 122. Ani Pharmaceuticals Main Business
Table 123. Ani Pharmaceuticals Latest Developments
Table 1. Gastroparesis Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Gastroparesis Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Prokinetic Agents
Table 4. Major Players of Antiemetic Agents
Table 5. Major Players of Others
Table 6. Global Gastroparesis Drugs Sales by Type (2019-2024) & (Kg)
Table 7. Global Gastroparesis Drugs Sales Market Share by Type (2019-2024)
Table 8. Global Gastroparesis Drugs Revenue by Type (2019-2024) & ($ million)
Table 9. Global Gastroparesis Drugs Revenue Market Share by Type (2019-2024)
Table 10. Global Gastroparesis Drugs Sale Price by Type (2019-2024) & (US$/mg)
Table 11. Global Gastroparesis Drugs Sales by Application (2019-2024) & (Kg)
Table 12. Global Gastroparesis Drugs Sales Market Share by Application (2019-2024)
Table 13. Global Gastroparesis Drugs Revenue by Application (2019-2024)
Table 14. Global Gastroparesis Drugs Revenue Market Share by Application (2019-2024)
Table 15. Global Gastroparesis Drugs Sale Price by Application (2019-2024) & (US$/mg)
Table 16. Global Gastroparesis Drugs Sales by Company (2019-2024) & (Kg)
Table 17. Global Gastroparesis Drugs Sales Market Share by Company (2019-2024)
Table 18. Global Gastroparesis Drugs Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Gastroparesis Drugs Revenue Market Share by Company (2019-2024)
Table 20. Global Gastroparesis Drugs Sale Price by Company (2019-2024) & (US$/mg)
Table 21. Key Manufacturers Gastroparesis Drugs Producing Area Distribution and Sales Area
Table 22. Players Gastroparesis Drugs Products Offered
Table 23. Gastroparesis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Gastroparesis Drugs Sales by Geographic Region (2019-2024) & (Kg)
Table 27. Global Gastroparesis Drugs Sales Market Share Geographic Region (2019-2024)
Table 28. Global Gastroparesis Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Gastroparesis Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Gastroparesis Drugs Sales by Country/Region (2019-2024) & (Kg)
Table 31. Global Gastroparesis Drugs Sales Market Share by Country/Region (2019-2024)
Table 32. Global Gastroparesis Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Gastroparesis Drugs Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Gastroparesis Drugs Sales by Country (2019-2024) & (Kg)
Table 35. Americas Gastroparesis Drugs Sales Market Share by Country (2019-2024)
Table 36. Americas Gastroparesis Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Gastroparesis Drugs Revenue Market Share by Country (2019-2024)
Table 38. Americas Gastroparesis Drugs Sales by Type (2019-2024) & (Kg)
Table 39. Americas Gastroparesis Drugs Sales by Application (2019-2024) & (Kg)
Table 40. APAC Gastroparesis Drugs Sales by Region (2019-2024) & (Kg)
Table 41. APAC Gastroparesis Drugs Sales Market Share by Region (2019-2024)
Table 42. APAC Gastroparesis Drugs Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Gastroparesis Drugs Revenue Market Share by Region (2019-2024)
Table 44. APAC Gastroparesis Drugs Sales by Type (2019-2024) & (Kg)
Table 45. APAC Gastroparesis Drugs Sales by Application (2019-2024) & (Kg)
Table 46. Europe Gastroparesis Drugs Sales by Country (2019-2024) & (Kg)
Table 47. Europe Gastroparesis Drugs Sales Market Share by Country (2019-2024)
Table 48. Europe Gastroparesis Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Gastroparesis Drugs Revenue Market Share by Country (2019-2024)
Table 50. Europe Gastroparesis Drugs Sales by Type (2019-2024) & (Kg)
Table 51. Europe Gastroparesis Drugs Sales by Application (2019-2024) & (Kg)
Table 52. Middle East & Africa Gastroparesis Drugs Sales by Country (2019-2024) & (Kg)
Table 53. Middle East & Africa Gastroparesis Drugs Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Gastroparesis Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Gastroparesis Drugs Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Gastroparesis Drugs Sales by Type (2019-2024) & (Kg)
Table 57. Middle East & Africa Gastroparesis Drugs Sales by Application (2019-2024) & (Kg)
Table 58. Key Market Drivers & Growth Opportunities of Gastroparesis Drugs
Table 59. Key Market Challenges & Risks of Gastroparesis Drugs
Table 60. Key Industry Trends of Gastroparesis Drugs
Table 61. Gastroparesis Drugs Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Gastroparesis Drugs Distributors List
Table 64. Gastroparesis Drugs Customer List
Table 65. Global Gastroparesis Drugs Sales Forecast by Region (2025-2030) & (Kg)
Table 66. Global Gastroparesis Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Gastroparesis Drugs Sales Forecast by Country (2025-2030) & (Kg)
Table 68. Americas Gastroparesis Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Gastroparesis Drugs Sales Forecast by Region (2025-2030) & (Kg)
Table 70. APAC Gastroparesis Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Gastroparesis Drugs Sales Forecast by Country (2025-2030) & (Kg)
Table 72. Europe Gastroparesis Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Gastroparesis Drugs Sales Forecast by Country (2025-2030) & (Kg)
Table 74. Middle East & Africa Gastroparesis Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Gastroparesis Drugs Sales Forecast by Type (2025-2030) & (Kg)
Table 76. Global Gastroparesis Drugs Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Gastroparesis Drugs Sales Forecast by Application (2025-2030) & (Kg)
Table 78. Global Gastroparesis Drugs Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Sumitomo Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Sumitomo Gastroparesis Drugs Product Portfolios and Specifications
Table 81. Sumitomo Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 82. Sumitomo Main Business
Table 83. Sumitomo Latest Developments
Table 84. Cadila Pharmaceuticals Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Cadila Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
Table 86. Cadila Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 87. Cadila Pharmaceuticals Main Business
Table 88. Cadila Pharmaceuticals Latest Developments
Table 89. Sanofi Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Sanofi Gastroparesis Drugs Product Portfolios and Specifications
Table 91. Sanofi Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 92. Sanofi Main Business
Table 93. Sanofi Latest Developments
Table 94. Teva Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Teva Gastroparesis Drugs Product Portfolios and Specifications
Table 96. Teva Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 97. Teva Main Business
Table 98. Teva Latest Developments
Table 99. Johnson & Johnson Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Johnson & Johnson Gastroparesis Drugs Product Portfolios and Specifications
Table 101. Johnson & Johnson Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 102. Johnson & Johnson Main Business
Table 103. Johnson & Johnson Latest Developments
Table 104. Pfizer Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer Gastroparesis Drugs Product Portfolios and Specifications
Table 106. Pfizer Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 107. Pfizer Main Business
Table 108. Pfizer Latest Developments
Table 109. Kyowa Kirin Pharmaceuticals Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
Table 111. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 112. Kyowa Kirin Pharmaceuticals Main Business
Table 113. Kyowa Kirin Pharmaceuticals Latest Developments
Table 114. Hanmi Pharm Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Hanmi Pharm Gastroparesis Drugs Product Portfolios and Specifications
Table 116. Hanmi Pharm Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 117. Hanmi Pharm Main Business
Table 118. Hanmi Pharm Latest Developments
Table 119. Ani Pharmaceuticals Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Ani Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
Table 121. Ani Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 122. Ani Pharmaceuticals Main Business
Table 123. Ani Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Gastroparesis Drugs
Figure 2. Gastroparesis Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gastroparesis Drugs Sales Growth Rate 2019-2030 (Kg)
Figure 7. Global Gastroparesis Drugs Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Gastroparesis Drugs Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Prokinetic Agents
Figure 10. Product Picture of Antiemetic Agents
Figure 11. Product Picture of Others
Figure 12. Global Gastroparesis Drugs Sales Market Share by Type in 2023
Figure 13. Global Gastroparesis Drugs Revenue Market Share by Type (2019-2024)
Figure 14. Gastroparesis Drugs Consumed in Diabetic Gastroparesis
Figure 15. Global Gastroparesis Drugs Market: Diabetic Gastroparesis (2019-2024) & (Kg)
Figure 16. Gastroparesis Drugs Consumed in Idiopathic Gastroparesis
Figure 17. Global Gastroparesis Drugs Market: Idiopathic Gastroparesis (2019-2024) & (Kg)
Figure 18. Global Gastroparesis Drugs Sales Market Share by Application (2023)
Figure 19. Global Gastroparesis Drugs Revenue Market Share by Application in 2023
Figure 20. Gastroparesis Drugs Sales Market by Company in 2023 (Kg)
Figure 21. Global Gastroparesis Drugs Sales Market Share by Company in 2023
Figure 22. Gastroparesis Drugs Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Gastroparesis Drugs Revenue Market Share by Company in 2023
Figure 24. Global Gastroparesis Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Gastroparesis Drugs Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Gastroparesis Drugs Sales 2019-2024 (Kg)
Figure 27. Americas Gastroparesis Drugs Revenue 2019-2024 ($ Millions)
Figure 28. APAC Gastroparesis Drugs Sales 2019-2024 (Kg)
Figure 29. APAC Gastroparesis Drugs Revenue 2019-2024 ($ Millions)
Figure 30. Europe Gastroparesis Drugs Sales 2019-2024 (Kg)
Figure 31. Europe Gastroparesis Drugs Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Gastroparesis Drugs Sales 2019-2024 (Kg)
Figure 33. Middle East & Africa Gastroparesis Drugs Revenue 2019-2024 ($ Millions)
Figure 34. Americas Gastroparesis Drugs Sales Market Share by Country in 2023
Figure 35. Americas Gastroparesis Drugs Revenue Market Share by Country in 2023
Figure 36. Americas Gastroparesis Drugs Sales Market Share by Type (2019-2024)
Figure 37. Americas Gastroparesis Drugs Sales Market Share by Application (2019-2024)
Figure 38. United States Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Gastroparesis Drugs Sales Market Share by Region in 2023
Figure 43. APAC Gastroparesis Drugs Revenue Market Share by Regions in 2023
Figure 44. APAC Gastroparesis Drugs Sales Market Share by Type (2019-2024)
Figure 45. APAC Gastroparesis Drugs Sales Market Share by Application (2019-2024)
Figure 46. China Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Gastroparesis Drugs Sales Market Share by Country in 2023
Figure 54. Europe Gastroparesis Drugs Revenue Market Share by Country in 2023
Figure 55. Europe Gastroparesis Drugs Sales Market Share by Type (2019-2024)
Figure 56. Europe Gastroparesis Drugs Sales Market Share by Application (2019-2024)
Figure 57. Germany Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Gastroparesis Drugs Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Gastroparesis Drugs Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Gastroparesis Drugs Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Gastroparesis Drugs Sales Market Share by Application (2019-2024)
Figure 66. Egypt Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Gastroparesis Drugs in 2023
Figure 72. Manufacturing Process Analysis of Gastroparesis Drugs
Figure 73. Industry Chain Structure of Gastroparesis Drugs
Figure 74. Channels of Distribution
Figure 75. Global Gastroparesis Drugs Sales Market Forecast by Region (2025-2030)
Figure 76. Global Gastroparesis Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Gastroparesis Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Gastroparesis Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Gastroparesis Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Gastroparesis Drugs Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Gastroparesis Drugs
Figure 2. Gastroparesis Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gastroparesis Drugs Sales Growth Rate 2019-2030 (Kg)
Figure 7. Global Gastroparesis Drugs Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Gastroparesis Drugs Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Prokinetic Agents
Figure 10. Product Picture of Antiemetic Agents
Figure 11. Product Picture of Others
Figure 12. Global Gastroparesis Drugs Sales Market Share by Type in 2023
Figure 13. Global Gastroparesis Drugs Revenue Market Share by Type (2019-2024)
Figure 14. Gastroparesis Drugs Consumed in Diabetic Gastroparesis
Figure 15. Global Gastroparesis Drugs Market: Diabetic Gastroparesis (2019-2024) & (Kg)
Figure 16. Gastroparesis Drugs Consumed in Idiopathic Gastroparesis
Figure 17. Global Gastroparesis Drugs Market: Idiopathic Gastroparesis (2019-2024) & (Kg)
Figure 18. Global Gastroparesis Drugs Sales Market Share by Application (2023)
Figure 19. Global Gastroparesis Drugs Revenue Market Share by Application in 2023
Figure 20. Gastroparesis Drugs Sales Market by Company in 2023 (Kg)
Figure 21. Global Gastroparesis Drugs Sales Market Share by Company in 2023
Figure 22. Gastroparesis Drugs Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Gastroparesis Drugs Revenue Market Share by Company in 2023
Figure 24. Global Gastroparesis Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Gastroparesis Drugs Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Gastroparesis Drugs Sales 2019-2024 (Kg)
Figure 27. Americas Gastroparesis Drugs Revenue 2019-2024 ($ Millions)
Figure 28. APAC Gastroparesis Drugs Sales 2019-2024 (Kg)
Figure 29. APAC Gastroparesis Drugs Revenue 2019-2024 ($ Millions)
Figure 30. Europe Gastroparesis Drugs Sales 2019-2024 (Kg)
Figure 31. Europe Gastroparesis Drugs Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Gastroparesis Drugs Sales 2019-2024 (Kg)
Figure 33. Middle East & Africa Gastroparesis Drugs Revenue 2019-2024 ($ Millions)
Figure 34. Americas Gastroparesis Drugs Sales Market Share by Country in 2023
Figure 35. Americas Gastroparesis Drugs Revenue Market Share by Country in 2023
Figure 36. Americas Gastroparesis Drugs Sales Market Share by Type (2019-2024)
Figure 37. Americas Gastroparesis Drugs Sales Market Share by Application (2019-2024)
Figure 38. United States Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Gastroparesis Drugs Sales Market Share by Region in 2023
Figure 43. APAC Gastroparesis Drugs Revenue Market Share by Regions in 2023
Figure 44. APAC Gastroparesis Drugs Sales Market Share by Type (2019-2024)
Figure 45. APAC Gastroparesis Drugs Sales Market Share by Application (2019-2024)
Figure 46. China Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Gastroparesis Drugs Sales Market Share by Country in 2023
Figure 54. Europe Gastroparesis Drugs Revenue Market Share by Country in 2023
Figure 55. Europe Gastroparesis Drugs Sales Market Share by Type (2019-2024)
Figure 56. Europe Gastroparesis Drugs Sales Market Share by Application (2019-2024)
Figure 57. Germany Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Gastroparesis Drugs Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Gastroparesis Drugs Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Gastroparesis Drugs Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Gastroparesis Drugs Sales Market Share by Application (2019-2024)
Figure 66. Egypt Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Gastroparesis Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Gastroparesis Drugs in 2023
Figure 72. Manufacturing Process Analysis of Gastroparesis Drugs
Figure 73. Industry Chain Structure of Gastroparesis Drugs
Figure 74. Channels of Distribution
Figure 75. Global Gastroparesis Drugs Sales Market Forecast by Region (2025-2030)
Figure 76. Global Gastroparesis Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Gastroparesis Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Gastroparesis Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Gastroparesis Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Gastroparesis Drugs Revenue Market Share Forecast by Application (2025-2030)
